Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EpisodicStatinMig. A Multicentre, Triple Blind, Placebo Controlled, Parallel Group Study of Atorvastatin in Episodic Migraine

NCT06248671 is registered in ClinicalTrials.gov with St. Olavs Hospital as lead sponsor.

NCT NCT06248671
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06248671 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EpisodicStatinMig. A Multicentre, Triple Blind, Placebo Controlled, Parallel Group Study of Atorvastatin in Episodic Migraine
Lead sponsor
St. Olavs Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
May 1, 2024
Completion date
February 28, 2029
Enrollment
450 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

episodic migraine